U.K., Drug Companies Announce $100M Venture Capital Fund For Dementia Research, As U.N. Opens First-Ever Dementia Conference
Financial Times: Dementia research boosted by $100m venture capital fund
“Research into dementia is to be boosted by a $100m venture capital fund backed by the U.K. government and several of the world’s biggest pharmaceuticals companies…” (Ward, 3/17).
Reuters: Dementia drug research aided by $100 million venture capital fund
“…The global Dementia Discovery Fund is unique in focusing on a single difficult to treat disorder and in bringing together industry and government. Drug companies involved include GlaxoSmithKline, Johnson & Johnson, Eli Lilly, Pfizer, and Biogen Idec…” (Hirschler, 3/17).
U.N. News Centre: Countries urged to make dementia public health priority as U.N. conference opens in Geneva
“The United Nations World Health Organization (WHO) today opened the first-ever Ministerial Conference on Global Action Against Dementia by reminding health ministers from around the world, experts, and civil society representatives that every four seconds someone is diagnosed with the incurable disease…” (3/16).